Three companies in the biomedical russians would be able to produce in an industrial process since September, a vaccine developed by the laboratory Gamaleïa.
Russia has assured this Monday that it would soon be able to produce hundreds of thousands of doses of vaccines per month, compared with the new coronavirus-and “several million” at the beginning of the next year.
ALSO READ >> Between alliances and provocations, the battle of the vaccines begins between the States
According to the Russian minister of Trade, Denis Mantourov, three companies biomedical will be able to produce as early as September and industrial way, a vaccine developed by the laboratory for research in epidemiology and microbiology Nikolai Gamaleïa. “According to preliminary estimates, ( … ) we will be able to provide starting this year, hundreds of thousands of doses of vaccine per month, then up to several million early next year”, he specified to the public agency TASS.
summer Offer : Take advantage of the special offer 2 months for 1€ I subscribe
Russia has been working on for months, like many other countries in the world, on several vaccine projects against the Covid-19. The one developed by the centre Gamaleïa is in collaboration with the ministry of Defence. A second prototype vaccine is designed at the Center of the state of research, Vektor, Siberia, and the first doses are expected in the month of October, according to the authorities.
No published studies for the moment
The Russian, ranked fourth in the world for the number of infections after the United States, Brazil and India, was proclaimed in April its commitment to be among the first countries, or even the first, to create a vaccine against the virus.
Read our complete file
Covid-19 : the race to vaccines
The Express audio available : the race for vaccines, anti-Covid Between alliances and provocations, the battle of the vaccines begins between the States Covid-19 : 300 million doses of vaccine are reserved by the european Commission
researchers have, however, expressed their concern at the rapidity of the development of vaccines russians, considering that some steps might be skipped in order to speed up the work pressure of the authorities, who have compared this race to the vaccine at the launch by the USSR in 1957 of the first artificial satellite, Sputnik. So far, Russia has not published a detailed study of the results of its testing to determine the effectiveness of the products that she is said to have developed.
